Trade Mark Journal No.2026/027 3 July 2026
WO0000001922380 (5)
Office of origin: United States of America
Date of International Registration:17 February 2026
Date of designation in the UK:
17 February 2026

International priority date claimed: 19 August 2025
(United States of America)
(99345299)
- Class 5
- Pharmaceutical compounding kits for veterinary use, namely, kits for compounding pharmaceuticals comprised primarily of pre-weighed, pre-measured pharmaceutical base preparations targeting thyroid disorders, neurological disorders, antimicrobial agents, cardiovascular disorders, gastro-intestinal disorders, treatment of chronic pain and acute pain, and treatment for inflammation.
BridgeHealth Pharmaceuticals, Inc.
Representative: Douglas R. Wolf Wolf Greenfield & Sacks, P.C., 600 Atlantic Avenue, Boston MA 02210, UNITED STATES OF AMERICA